Acute Kidney Injury

Genetic Loci Linked to Acute Kidney Injury

Genetic Loci Linked to Acute Kidney Injury

Four single-nucleotide polymorphisms at two loci identified in discovery, replication populations.

Hyperphosphatemia Linked With Mortality in Septic AKI

Hyperphosphatemia Linked With Mortality in Septic AKI

By

Hyperphosphatemia was associated with more than double the risk of death from any cause.

Better AKI Patient Survival Linked to Negative Fluid Balance

Better AKI Patient Survival Linked to Negative Fluid Balance

By

The mortality rate among patients with negative fluid balance was just 7.4%, compared with 43.5% for patients with a positive fluid balance.

Acute Kidney Injury Progression Predicted by Urinary Biomarkers

Acute Kidney Injury Progression Predicted by Urinary Biomarkers

By

Study identifies 3 biomarkers that could detect increasing risk of worsening AKI in patients with acute cardiorenal syndrome.

More Intensive Renal Replacement Therapy Possibly Harmful

More Intensive Renal Replacement Therapy Possibly Harmful

By

This approach is associated with lower urine output during the first 7 days of therapy.

Drug Combinations May Increase Acute Kidney Injury Risk

Drug Combinations May Increase Acute Kidney Injury Risk

NSAIDs + diuretics with or without additional renin-angiotensin aldosterone agents demonstrated the strongest level of evidence.

Acute Kidney Injury May Up Long-Term Risk of Cardiovascular Mortality

Acute Kidney Injury May Up Long-Term Risk of Cardiovascular Mortality

By

In a meta-analysis, AKI was associated with an 86% increased risk of CV-related death and 38% increased risk of other major CV events.

FDA Strengthens AKI Warning for Some SGLT2 Inhibitors

FDA Strengthens AKI Warning for Some SGLT2 Inhibitors

The Food and Drug Administration (FDA) announced it is strengthening the current warning about the risk of acute kidney injury for drug products containing canagliflozin (Invokana, Invokamet) and dapagliflozin (Farxiga, Xigduo XR).

CKD Progression After Acute Kidney Injury Characterized

CKD Progression After Acute Kidney Injury Characterized

By

Male gender, diabetes, and renal function decline at 90 days implicated as risk factors; patients rarely progress to end-stage renal disease.

Fluid Overload at RRT Initiation Ups AKI Patients' Long-Term Mortality

Fluid Overload at RRT Initiation Ups AKI Patients' Long-Term Mortality

By

Japanese study demonstrates a 2-fold increased risk of death from any cause.

In-Hospital Mortality From Dialysis-Requiring AKI Declining

In-Hospital Mortality From Dialysis-Requiring AKI Declining

By

Patients were 40% less likely to die in 2011 compared with 2001, study finds.

Critically Ill Acute Kidney Injury Patients Benefit From Early RRT

Critically Ill Acute Kidney Injury Patients Benefit From Early RRT

By

Study demonstrates improved 90-day survival and greater likelihood of recovering renal function.

Risk Factors ID'd for Early Mortality After Starting CRRT

Risk Factors ID'd for Early Mortality After Starting CRRT

By

High FiO2 and norepinephrine in AKI patients increases their risk of death within 24 hours of being placed on continuous renal replacement therapy.

No Survival Advantage With Early Renal-Replacement Therapy in AKI

No Survival Advantage With Early Renal-Replacement Therapy in AKI

Mortality no different for early versus delayed strategy for patients with severe acute kidney injury.

AKI After RCC Surgery On the Rise

AKI After RCC Surgery On the Rise

By

Nearly 6% of patients who underwent partial or radical nephrectomy between 1998 and 2010 developed AKI.

Hospital- vs Community-Acquired AKI

Hospital- vs Community-Acquired AKI

Poor long-term outcomes found even in patients with community-acquired AKI but not hospitalized.

No Benefit, Kidney Risk Found for Perioperative Statins

No Benefit, Kidney Risk Found for Perioperative Statins

Statins don't prevent complications and may cause acute kidney injury, researchers report.

ACEI/ARBs Improve AMI Outcomes Regardless of Kidney Function

ACEI/ARBs Improve AMI Outcomes Regardless of Kidney Function

Treatment linked to improved long-term survival, regardless of underlying kidney function.

CMX-2043 Did Not Reduce Contrast-Induced Nephropathy

CMX-2043 Did Not Reduce Contrast-Induced Nephropathy

CARIN trial reported no significant differences in acute kidney injury incidence between novel compound CMX-2043 and placebo.

Aliskiren/Enalapril Combo Results in More Harms in Heart Failure

Aliskiren/Enalapril Combo Results in More Harms in Heart Failure

The addition of aliskiren to enalapril led to more adverse events in patients with chronic heart failure without an increase in benefit.

ACE Inhibitors, ARBs Comparable for Diabetic Retinopathy Patients

ACE Inhibitors, ARBs Comparable for Diabetic Retinopathy Patients

By

Study finds no significant difference in the rates of all-cause mortality, major cardiac events, and hospital admission with hyperkalemia or AKI.

World Kidney Day 2016 Focuses on Disease in Childhood

World Kidney Day 2016 Focuses on Disease in Childhood

10% of the population worldwide is impacted by some form of kidney damage.

Peri-Op Statin Therapy Does Not Prevent AKI After Cardiac Surgery

Peri-Op Statin Therapy Does Not Prevent AKI After Cardiac Surgery

The trial was stopped for futility after 615 patients completed the study.

Peri-Op Statin Therapy Does Not Prevent AKI After Cardiac Surgery

Peri-Op Statin Therapy Does Not Prevent AKI After Cardiac Surgery

The trial was stopped for futility after 615 patients completed the study.

AKI After Cardiac Surgery Linked to Worse Survival, Renal Outcomes

AKI After Cardiac Surgery Linked to Worse Survival, Renal Outcomes

By

Acute kidney injury increased the likelihood of advanced chronic kidney disease in elderly patients.

Statin Use May Raise Kidney Disease Risk

Statin Use May Raise Kidney Disease Risk

By

Statin users had 30% increased odds of acute kidney injury and 36% increased odds of chronic kidney disease compared with non-users.

IV Iron Safe for Treating Anemia in Acute Kidney Injury Patients

IV Iron Safe for Treating Anemia in Acute Kidney Injury Patients

By

In a case-control study, the treatment did not adversely affect mortality or recovery from AKI.

AKI Diagnostic Testing May Be Excessive

AKI Diagnostic Testing May Be Excessive

By

Results of some urine and blood tests are unlikely to affect diagnosis or management of acute kidney injury.

CKD Risk Following Inpatient Acute Kidney Injury Characterized

CKD Risk Following Inpatient Acute Kidney Injury Characterized

By

Even mild AKI with rapid recovery is associated with increased risk of chronic kidney disease stage 3 or higher.

Long-Term Cardiovascular Mortality Linked to Post-Op AKI, CKD

Long-Term Cardiovascular Mortality Linked to Post-Op AKI, CKD

By

Even surgery patients with stage 1 AKI without true organ damage had a 43% increase in cardiovascular mortality risk within 10 years compared with patients with no kidney disease.

Sign Up for Free e-newsletters